ABSTRACT-Background: The neonatal innate immune system differs to microbial infection both quantitatively and qualitatively when compared with adults. Here, we provide the first genome-wide ex-vivo expression profile of umbilical cord blood (UCB) neutrophils from full-term infants prior to and in response to whole-blood lipopolysaccharide (LPS) stimulation. Additionally, we provide cytokine expression prior to and following LPS stimulation. The genomic expression and cytokine profile are compared with LPS-stimulated whole blood from healthy adult subjects (HC). Methods: Whole blood from UCB (n ¼ 6) and HC (n ¼ 6) was studied at baseline or was stimulated for 24 h with 100 ngs/mL of LPS. CD66b þ neutrophils were subsequently isolated with microfluidic techniques and genome-wide expression analyses were performed. Ingenuity Pathway Analysis (IPA) software was utilized to predict downstream functional effects. Additionally, cytokine concentrations in whole blood prior to and after 24 h of LPS incubation were determined. Results: LPS stimulated whole blood from UCB demonstrated significant differences in both ex-vivo cytokine production and PMN gene expression. Mixed-effect modeling identified 1,153 genes whose expression changed significantly in UCB and HC after exposure to LPS (P <0.001 with a minimum 1.5-fold change). IPA downstream predictions suggest that PMNs from UCB fail to effectively upregulate genes associated with activation, phagocytosis, and chemotaxis in response to LPS stimulation. Furthermore, whole blood from UCB showed increased interleukin (IL)-10 production to LPS, but failed to significantly increase several pro-inflammatory cytokines. Conclusions: LPS-stimulated whole blood from UCB exhibited a markedly suppressed inflammatory cytokine production and PMN innate immune genome response. These differences in gene expression and cytokine production may be an adaptive response to a prior fetal environment, but may also explain their increased susceptibility to infections. Characterization of these deficits is the first step toward developing prophylactic and therapeutic interventions.
INTRODUCTION
Infections are responsible for nearly half of the 3 million neonatal deaths that occur annually (1) and sepsis is the number one cause of neonatal morbidity worldwide (2) . Additionally, the annual costs of treating neonatal infection and sepsis are estimated to be $1.7 billion in the United States alone in 2005 (3) . The prevention of infection remains the most promising approach to reducing mortality and the morbidity in this highly vulnerable population.
Prior murine research and early human studies suggest that the innate and not the adaptive immune system is most crucial in preventing infection in the newborn, and that the neonatal innate immune system has both quantitative and qualitative deficits (4) (5) (6) (7) (8) . By validating prior murine findings, and working to fully characterize the deficits of the human neonate's innate immune system, we can work to better identify neonates at risk of infectious complications and begin to develop therapies aimed at correcting these deficits potentially providing prophylactic interventions to infants most at risk.
With the advent of intra-partum antibiotic use to combat Group B streptococcus, Escherichia coli has emerged as the primary causative pathogen within 72 h of life in preterm infants, and as the second most common cause in full-term infants (9) . Here, we utilized lipopolysaccharide (LPS), an endotoxin released from gram-negative microbes such as E coli, to delineate how the innate immune system, specifically the neutrophil, of the neonate responds to an infectious insult in an ex-vivo model.
Investigation of the neonatal immune system has two significant limitations: the inability to collect an adequate volume of blood from neonates weighing as little as 500 g, and concerns regarding the risk:benefit of human investigations in neonates as a vulnerable population. By using umbilical cord as a source of neonatal blood, we have noninvasively obtained blood samples from newborns without posing any additional risk to the neonate. We recognize that cord blood samples contain some maternal contamination, but the quantities are general minimal ($1%) and are usually discounted (10) . In addition, by using microfluidic techniques to isolate neutrophils from miniscule quantities of blood (11) , we have minimized volume requirements for future studies with direct neonatal blood sampling.
Here, we present the first genome-wide ex-vivo expression profile of cord blood neutrophils in response to ex-vivo whole blood LPS stimulation. The transcriptomic profiles of neutrophils obtained from full-term infant umbilical cord blood (UCB) and from adult healthy control subjects (HC) at both rest and 24 h following LPS stimulation are compared. Ex-vivo whole blood cytokine expression and neutrophil genome-wide expression analyses were performed, and down-stream signaling pathways were extrapolated from the change of individual gene transcription of neutrophils in response to ex-vivo LPS stimulation. This analysis required less than 1 mL of blood.
PATIENTS AND METHODS

Data and sample collection
UCB sample collection from full-term infants was approved by the University of Florida Institutional Review Board with a waiver of consent. UCB is considered a waste product; blood was collected by laboratory personnel from isolated segments of umbilical cord via needle puncture in the delivery room shortly after birth. A brief questionnaire was filled out by nursing staff that included gestational age, gender, weight, mechanism of birth, and presence of any known perinatal infectious concerns. The cord blood came from full-term infants (>38-week gestation) undergoing normal vaginal delivery with no documented complications. Cord blood samples were not based on race, age or ethnicity of the parents, or the sex of the infant. Study staff were not permitted access to electronic medical records or have patient contact due to waiver of consent. Blood from HC was collected by venipuncture from healthy young adults (25-45 years old), after informed consent was obtained. Healthy adult subjects claimed no recent medical history, no history of autoimmune disease or cancer, and were not taking any medications, including nonsteroidal antiinflammatory agents.
Within an hour of blood draw, neutrophil genomics and whole blood cytokine concentrations were determined on aliquots of blood obtained from UCB and HC. Remaining UCB and HC whole blood aliquots were incubated at 378C in a CO 2 -controlled incubator with highly purified LPS (100 ng per milliliter of blood; ultrapure via ion exchange chromatography Escherichia coli O26:B6 (Sigma-Aldrich, St. Louis, Mo) overnight. Preliminary studies were conducted on cord blood purchased from the New York Blood Bank, and were stimulated with increasing quantities of LPS (1, 10, 100, and 1,000 ngs/mL). One hundred ngs/mL was selected based on the greatest ex-vivo cytokine production (data not shown). Unstimulated controls were performed at baseline rather than after 24 h of no stimulation for two reasons. First, the null hypothesis was that the change in PMN gene expression in response to LPS from neonates was not different than from adults. Second, measuring this change after 24 h of no stimulation is difficult because of the relative short half-lives of nonstimulated human neutrophils. Estimates of the half-life of neutrophils in the circulation have varied from 6 h to 5 days and whether the half-lives differ in neonates versus adults is unknown (12, 13) .
Cytokine analysis
Whole blood was centrifuged at 1,500 Â g for 8 min at 48C, and the supernatant was collected and stored in an À808C freezer. At the completion of sample collection, concentrations of interleukin (IL)-1b, IL-4, IL-6, IL-10, IL-12, IFN], TNFa, MIP-1a, MCP-1, GRO, and IP-10 were determined using Milliplex kits (Millipore, Darmstadt, Germany) on the Luminex MAGpix Multiplex reader.
Genomic analysis
Neutrophils were isolated from whole blood using anti-CD66b monoclonal antibody coated microfluidic devices as previously described (14) . The cassettes capture a fixed number of PMNs (between 5 and 10 Â 10 6 cells), so that the total numbers of PMNs captured were equivalent between UCB and HC samples, regardless of the total or differential counts. Isolated neutrophils were then lysed en bloc using RLT buffer (Qiagen, Valencia, Calif), and the cell lysate was run through a QiaShredder column and samples were stored in an À808C freezer. RNA was extracted from lysates using QIAGEN RNeasy Mini Kit (Qiagen). RNA integrity was assessed with an Agilent 2100 Bioanalyzer (Santa Clara, Calif). RNA was labeled using Nugen (NuGEN Technologies Inc, San Carlos, Calif) Ovation Pico WTA System V2. Resulting cDNA was labeled, fragmented using Nugen Encore Biotin Module, hybridized onto GeneChip Human Transcriptome Array 2.0 (Affymetrix, Santa Clara, Calif) and processed following manufacturer's instructions.
Gene expression profile and statistical analysis
Microarray expression was normalized using RMA as implemented in Partek (Partek Inc, St Louis, Mo). Differences in gene expression between UCB and HC samples, both unstimulated and LPS-stimulated, were identified using both ANOVA and a linear mixed-effects model with a false discovery adjusted probability of P <0.001. The mixed effects model better handles related cohorts that have markedly different variances. The expression of genes significant at P <0.001 with a minimum 2-fold change to distinguish between UCB and HC patients, or between unstimulated and LPS stimulation, was confirmed using leave-one-out-cross-validation studies and Monte Carlo simulations with class prediction tools implemented in BRB-ArrayTools Version: 4.5.0 -Beta_1 Release, developed by Richard Simon and BRB-ArrayTools Development Team (http://linus.nci.nih.gov/BRB-ArrayTools.html).
Gene Ontology and BioCarta Pathway analysis was conducted using BRB ArrayTools. These genes were further analyzed with Ingenuity Pathway Analysis (IPA) software. IPA software was employed to make downstream functional predictions from these groups of genes with a Z-score greater than two indicating significance.
Differences in cytokine concentration between UCB and HC, with and without LPS stimulation, were compared using Wilcoxon sign-rank test, as the cohorts failed tests of normality.
RESULTS
Genomic analysis
Initially, an unsupervised analysis was conducted using all 24 microarrays where the coefficient of variation for individual gene expression was set at 0.5. As shown in Figure 1A , 4,050 probe sets representing 3,762 genes had a variance of greater than 50%, and when hierarchically clustered, the gene expression patterns separated perfectly first between unstimulated samples and samples stimulated with LPS. Within each major subdivision, there was a further perfect separation between UCB and HC. When leave one out cross validation was used to predict the classification of samples into one of the four groups, the assignment was a perfect 100%, and a Monte Carlo simulation gave a probability of <0.001. The principal component analysis (PCA) in Figure 1B gives a better overall description of the sum of differences in gene expression between the four groups. As is evident, the differences in gene expression between UCB and HC were markedly greater after LPS stimulation that in unstimulated samples. Figure 1C depicts an ANOVA on the four groups of data, UCB prior to and after LPS stimulation and HC prior to and after LPS stimulation which identified 9,979 probes sets as significant (P <0.001 with a fold-change two cutoff) representing 9,296 unique genes. Figure 1D demonstrates the 6,166 probes sets whose mRNA abundance changed significantly from HC (P <0.001) in response to LPS stimulation which represented 5,757 unique genes, compared with only 3,741 probes sets representing 3,624 unique genes responding to LPS stimulation in PMNs from UCB. Two thousand three-hundred eighty-nine probes sets representing 2,311 genes were identified as changing in common in both HC and UCB.
Mixed-effect modeling identified 1,790 genes whose magnitude of change was significantly different between PMNs obtained from UCB and HC (P <0.001; from prior to after LPS stimulation). These genes were further evaluated and 1,153 genes were identified as having a minimum 1.5-fold change. Table 1 identifies the 10 genes most upregulated and down regulated from UCB and HC in response to LPS stimulation. Five of the 10 genes that are most up-regulated in adults and umbilical cord blood overlap (Panel A), but in every case, the magnitude of the increase is markedly less (from 85% to approximately 50%) in UCB samples. Four of the five genes are clearly involved in the inflammatory response, and even the fifth, the succinate receptor has been implicated as a coactivator of platelets (15) . There was no significant overlap in the 10 genes most down-regulated in response to LPS in PMNs from UCB and HC (Panel B). But, similar to that seen for upregulated genes, the magnitude of the changes in gene expression from UCB PMNs is markedly lower than from HC.
Significantly downregulated umbilical cord blood functional predictions IPA software was utilized to predict downstream effects from this neutrophil transcriptomic profile and revealed a general propensity of HC to upregulate expression of ontologies of genes related to neutrophil activation, phagocytosis, and chemotaxis, while UCB exhibited attenuated upregulation or downregulation of these same groups (Fig. 2 ).
Downstream predictions for these genes identified significant preponderance of genes involved in ''cytotoxicity,'' ''toxicity of cells,'' and ''killing of cells'' (Z ¼ À2.408; À2.136; À2.058, respectively) that were down-regulated in UCB; conversely in PMNs from HC, LPS stimulation showed a trend toward upregulation (Table 2) . Additionally, gene expression profiles involved in ''cell movement of neutrophils, granulocytes, and phagocytes'' (Z ¼ À3.011; À2.718; À2.081, respectively), ''apoptosis of hematopoietic cell lines'' (Z ¼ À2.027), ''phagocytosis of granulocytes'' (Z ¼ À2.191), ''synthesis of lipids'' (Z ¼ À2.504), ''synthesis and metabolism of eicosanoids'' (Z ¼ À2.150; À2.182), and ''metabolism of reactive oxygen species'' (Z ¼ À2.088) were all significantly downregulated in UCB after LPS stimulation whereas HC response was not significantly downregulated.
Significantly upregulated umbilical cord blood functional predictions
PMNs from UCB had overexpression of genes significantly upregulated in pathways linked to ''organismal death (Z ¼ 3.621) and morbidity and mortality'' (Z ¼ 3.472) as well as
Umbilical cord blood and healthy control subject gene expression. A, When the 4,050 probe sets (representing 3,762 genes) with a CoV >0.5 in the unsupervised analysis were hierarchically clustered, defining differences in the patterns of gene expression was first the presence or absence of LPS and second, the source of the PMNs. B, The unsupervised analysis of (A) was processed using principal component analysis (PCA) software that gives a better visual description of the sum of differences in gene expression between the four groups. Gene expression patterns from healthy control (HC) subjects (blue) and the umbilical cord blood (UCB [pink]) are tightly grouped to the right on Day 0; however, they respond differently to LPS exposure with the HC group clustering in the left upper corner and the UCB clustering in the lower center. C, Using a false discovery adjusted probability of P <0.001 and a 2-fold difference in expression, the temporal pattern of the expression of the LPS responsive genes differed between neutrophils from (UCB) (n ¼ 6) and HC subjects (n ¼ 6). There was a significant difference in the expression of 9,979 probe sets representing 9,296 unique genes between neutrophils isolated from UCB and HC subjects prior to and overnight after LPS exposure. D, Venn diagram showing the overlap between genes whose expression changed in response to LPS in the UCB and HC PMNs. Six thousand one-hundred sixty-six probe sets whose mRNA abundance changed significantly from HC (P <0.001) in response to LPS stimulation which represented 5,757 unique genes, compared with only 3,741 probes sets representing 3,624 unique genes responding to LPS stimulation in PMNs from UCB. Two thousand threehundred eighty-nine probes sets representing 2,311 genes were identified as changing in common in both HC and UCB. LPS indicates lipopolysaccharide. A, Top 10 genes whose expression increased in response to ex-vivo LPS stimulation. Five of the 10 genes are seen in both PMNs from UCB and HC; in every case, however, the increase was greater in PMNs from HC. Interestingly, only one gene on this list was expressed significantly greater in UCB: semenogelin (SEMG1). Degradation products of semenogelin are potent antimicrobials, including sgl29 (15). B, Top 10 genes whose expression is decreased in response to ex-vivo LPS stimulation. In this case, there is no overlap between expression patterns in PMNs isolated from UCB and HC. HC indicates healthy control; LPS, lipopolysaccharide; UCB, umbilical cord blood.
''quantity of blood cells, leukocytes, and neutrophils'' (Z ¼ 2.142; 2.240; 2.034, respectively) following LPS incubation; these were not significantly upregulated in HC.
Significant downregulated healthy control functional predictions
In contrast, PMNs from HC had overexpression of genes that were significantly downregulated involved in ''adhesion of neutrophils, granulocytes, and immune cells'' (Z ¼ À2.178; À2.337; À2.223) as well as ''binding of granulocytes, professional phagocytic cells, and leukocytes'' (Z ¼ À2.560; À2.302; À2.171, respectively); while expression of PMNs from UCB was downregulated but not significantly.
Significant upregulated healthy control functional predictions
PMNs from HC demonstrated overexpression of genes involved in the upregulation of ''activation of blood cells'' (Z ¼ 2.150) while PMNs from UCB were not significantly downregulated. Additionally, PMNs from HC showed upregulation of ''activation of antigen presenting cells, leukocytes, and phagocytes'' (Z ¼ 2.634; 2.407; 2.370, respectively), as well as ''immune response of antigen presenting cells'' (Z ¼ 2.417); UCB demonstrated upregulation that was attenuated and not significant.
Significantly upregulated healthy control signaling predictions
In addition to predicted functional effects, HC also demonstrated significantly increased ''signaling through I-kB kinase/ NF-kB cascade and protein kinase cascade'' (Z ¼ 2.262; 2.884) while UCB demonstrated an attenuated non-significant upregulation.
Cytokine analysis
In response to LPS, whole blood from HC significantly increased IFNg concentrations (P <0.01) while UCB demonstrated a non-significant decrease (Fig. 3) . IL-12 (P <0.01), MIP-1a (P <0.0001), TNF-a (P <0.005), IP-10 (P <0.0001) concentrations were all increased by LPS stimulation in HC, while whole blood stimulation from UCB had an attenuated non-significant increase in these cytokine concentrations. IL1b and IL-6 were significantly upregulated by LPS stimulation in both HC (P <0.005; P <0.01) and UCB (P <0.05; P <0.001) with a trend toward more robust response from HC; however, the fold change post-LPS incubation between HC and UCB was not statistically different. Whole blood from UCB had a significant increase in IL-10 (P <0.0001) following LPS stimulation, while HC showed an attenuated nonsignificant increase. Whole blood from UCB also had a trend toward greater increases in MCP-1 post-LPS stimulation The data shown represent 9,296 genes that are significantly different between the groups (P <0.001 with a fold-change two cutoff). Here, the orange represents over-representation of genes (upregulated) and the blue represents downregulated. The UCB shows almost global downregulation, or attenuated upregulation of genes involved in phagocytosis, chemotaxis, and activation after LPS exposure, whereas the adult favors a more upregulated transcriptomic profile. APCs indicates antigen presenting cells.
(P <0.0001) when compared with HC; however, the fold change (Day 0 vs. Day 1 post-LPS incubation) difference between HC and UCB stimulated whole blood was not statistically different and HC also had significant increase in MCP-1 (P <0.01).
DISCUSSION
Infection continues to be a significant cause of morbidity and mortality in the neonatal population. Previous research suggests that it is primarily the innate and not the adaptive immune system that plays the most crucial role in combating The transcriptomic upregulation or downregulation of 1,153 genes, identified by mixed-effect modeling (P < 0.001; with 1.5-fold-change cutoff) was analyzed by IPA software and significant downstream functional predictions (defined as À2.00 < Z >2.00) were identified for umbilical cord blood (UCB) and healthy control (HC). Here is a comparison of Z scores (from Day 0 vs. Day 1 after LPS) between UCB and HC. UCB demonstrated significant downregulation of cell movement, phagocytosis, apoptosis, cytotoxicity, and synthesis of lipids and eicosanoids. UCB had significant upregulation of genes responsible for quantity of neutrophils, as well as organismal death and morbidity and mortality. Although HC showed similar trends in these categories, the change was not significant. Conversely, HC demonstrated significant downregulation of adhesion and binding genes and significant upregulation of activation of immune cells and signaling pathways. Both UCB and HC significantly upregulated quantity of phagocytes, antigen presentation, and response of antigen presenting cells.
bacterial infection (4, 5) . While the innate immune system is a complex network, neutrophil function plays a predominant role in combating infections (16) . LPS, an endotoxin, has been shown to be a major mediator of neutrophil activation via TLR4 receptor signaling. Here, we compared neutrophil genomic and whole blood responses from full-term neonate UCB and compared it with HC volunteers to highlight the differences in neutrophil responsiveness following overnight LPS stimulation ex vivo. Surprisingly, gene expression patterns at baseline were surprisingly similar between PMNs obtained from full-term infants and healthy adult subjects; however, their responses to LPS were significantly different. To our knowledge, this is the first comparison of the genome-wide ex-vivo expression profile of neutrophils prior to and in response to LPS stimulation from cord blood. Prior microarray analysis has only been conducted on infected or septic children (17) (18) (19) (20) or in response to peptidoglycan (21) . Transcriptomic analysis of the PMN genome suggests that in response to LPS stimulation, PMNs from UCB have a reduced capacity to upregulate transcription of classes of genes related to neutrophil activation, phagocytosis, and chemotaxis when compared with PMNs from HC. Neutrophil   FIG. 3 . Cytokine responses following overnight incubation with lipopolysaccharide. In response to overnight whole-blood stimulation with lipopolysaccharide (LPS), healthy control (HC) significantly upregulated IFNg (P <0.01), IL-12 (P <0.01), MIP-1a (P <0.0001), TNFa (P <0.005), IP-10 (P <0.0001), while umbilical cord blood (UCB) had attenuated non-significant responses. IL-1b and IL-6 concentrations were significantly increased by both HC (P <0.005; P <0.01) and UCB (P <0.05; P <0.001). UCB had a significant increase in IL-10 (P <0.0001), while HC showed an attenuated non-significant increase. UCB also had a trend toward greater increase in MCP-1 post-LPS stimulation (P <0.0001) when compared with HC (P <0.01). IFNg indicates interferon gamma; IL, interleukin; LPS, lipopolysaccharide; TNF, tumor necrosis factor. activation has been shown to be influenced by length of labor (22) , but has not been well characterized at the level of genomic expression. Our findings concerning chemotaxis and phagocytosis are supported by prior functional studies that found a 60% decrease in neonatal neutrophil chemotaxis to the chemoattractant fMLP (23) , as well as a reduced phagocytic capacity (24, 25) . We are reluctant to define these differences in genomic and functional responses as being ''defective'' in the newborn, as they obviously reflect an evolutionary response to the fetal state and the transition to independence. However, a better understanding of these differences provides a potential target for future therapies aimed at facilitating the transition to a more adult-like state. Additionally, transcriptomic signatures may enable risk stratification and facilitate closer surveillance and more aggressive clinical management of high-risk neonates, while at the same time, minimizing interventional therapies and broad spectrum antibiotic use in low-risk neonates.
Whole-blood from HC stimulated with LPS exhibited significant increases in pro-inflammatory cytokine concentrations (INFg, IL-12, MIP-1a, TNFa, IL-1b, and IL-6), while whole blood from UCB showed only significantly increased IL-6 concentrations. Additionally, LPS stimulated HC blood exhibited a significant increase in IP-10 concentrations, a chemoattractant for monocytes, macrophages, T-cells, NK cells, and dendritic cells. Conversely, LPS-stimulated whole blood from UCB had significantly increased levels of the anti-inflammatory cytokine IL-10, which is known to downregulate T h1 polarization of T cells, decrease MHC II complexes on antigen presenting cells and block NF-kB translocation (26) . This cytokine profile in response to LPS incubation suggests that whole blood from UCB is unable to mount an inflammatory response to TLR4 stimulation which is likely to result in less T h1 T-cell polarization, less immune cell activation, and recruitment and poor antigen presentation (Fig. 3) . These results largely correlate with similar prior studies; however, these studies were limited by lack of comparison to HC or included a limited number of cytokines (27) (28) (29) . Our study uniquely demonstrates a significant increase in UCB IL-10 expression and fails to support a significant increase in UCB TNFa as reported by prior studies.
The shortcomings of this study are the low number of enrolled study participants which may be underpowered to detect all significant differences between UCB and HC. Our neonate study population is also limited to full-term infants due to the frequent use of cord blood ''milking'' at the time of delivery for preterm infants, whereby the umbilical cord blood is pushed back toward the infant and into the infant's circulatory system. Therefore, our study does not represent the population with the highest incidence of sepsis. However, we do believe that the shortcomings of the neonate's immune system are a continuum and continued study in preterm neonates will likely include the differences noted here in term infant UCB as well as additional differences. Finally, cord blood contains some maternal cells and plasma, so it is not a true reflection of the infant per se. However, the degree of maternal contamination is generally considered modest, and efforts to obtain sufficient quantities of blood for genomic and cytokine measurements directly from the newborn are often difficult. Due to the waiver of consent, we were limited in our ability to review the medical history of the mother and infant for infection; however, the absence of any known prenatal infectious complications was confirmed at the time of birth. Additionally, the information presented here reflects neutrophil transcription and either protein production or functional responses are needed to confirm whether these transcriptional changes translate into differences in PMN antimicrobial activity.
Future study will need to focus on neonatal blood collected at or around the time of birth from all viable gestational ages to fully characterize the gradation of unique changes exhibited by preterm and low-birth weight neonatal immune systems. Once the immune system is characterized, interventions aimed at reducing infections can be undertaken.
